Körmendy-Rácz, János (2025) When the Patient Is the Control: A Pragmatic Framework for Early-Phase Evaluation of Complex, Low-Risk Clinical Interventions. APIS, 2 (2). pp. 28-35. ISSN 3058-0382
|
Text
21252-ArticleText-84830-3-10-20251227.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (285kB) | Preview |
Abstract
BackgroundParallel control groups, particularly within randomized controlled trials, are widely regarded as the gold standard of clinical evidence. While indispensable for confirmatory and high-risk investigations, this paradigm may be ill-suited for early-phase evaluation of complex, multi-component, and low-risk interventions operating within real-world clinical systems.ObjectiveThis paper proposes a pragmatic methodological framework for evaluating such interventions without reliance on parallel control groups, while maintaining scientific rigor and ethical proportionality.MethodsWe synthesize methodological principles from longitudinal within-subject designs, complex systems theory, and risk-based research ethics. The framework rests on three core pillars: the use of patients as their own controls through stable baseline and pre–post comparisons, black-box, output-oriented validation prioritizing reproducible clinical outcomes over early mechanistic isolation, and safety-first justification grounded in the absence of known adverse effects and low iatrogenic risk. ResultsWe demonstrate that, under clearly defined conditions, control-free and within-subject designs can provide valid exploratory evidence, address common methodological criticisms—including placebo effects, natural disease course, and regression to the mean—and serve as a coherent first step in a phased research trajectory.ConclusionThe absence of a parallel control group does not imply the absence of methodological control. When applied proportionately and transparently,pragmatic, control-free frameworks can generate meaningful, reproducible clinical insights while guiding subsequent mechanistic and controlledinvestigations. This approach supports methodological pluralism and aligns evidentiary standards with intervention complexity, risk profile, and researchobjectives.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | placebo effect, evidence-based medicine, naturopathy, self-controlled study design, randomized controlled trial, pre–post analysis |
| Subjects: | R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan R Medicine / orvostudomány > RZ Other systems of medicine / orvostudomány egyéb területei |
| SWORD Depositor: | MTMT SWORD |
| Depositing User: | MTMT SWORD |
| Date Deposited: | 05 Jan 2026 10:32 |
| Last Modified: | 05 Jan 2026 10:32 |
| URI: | https://real.mtak.hu/id/eprint/231332 |
Actions (login required)
![]() |
Edit Item |




